Rs 1,820 Puts — Just Below Current Price — Draw 1,629 Contracts on Sun Pharmaceutical Industries Ltd

Put Options Event and Cash Market Context

On 26 May 2026, Sun Pharmaceutical Industries Ltd witnessed significant put option activity at the Rs 1,820 strike, with 1,629 contracts traded and a turnover of approximately ₹8.95 lakhs. The open interest at this strike stands at 2,000 contracts, indicating a moderate build-up of positions. The expiry date coincides with the trading day, adding urgency to the positioning.

The stock itself has been on a three-day losing streak, shedding 3.33% over this period, and underperforming its sector by 0.62% on the day. Despite this short-term weakness, the share price remains comfortably above its 20-day, 50-day, 100-day, and 200-day moving averages, though it is slightly below the 5-day moving average. Delivery volumes have risen by 15.37% compared to the five-day average, signalling increased investor participation in the cash market.

The juxtaposition of put activity near the money and a stock that has recently declined but remains technically supported raises the question: is this put buying a protective hedge or a directional bearish bet?

Strike Price Analysis: Moneyness and Intent

The Rs 1,820 strike sits just 0.7% below the current underlying price of Rs 1,833.40, placing these puts effectively at-the-money (ATM). This proximity is critical in interpreting the intent behind the activity. ATM puts are often purchased either as a hedge against near-term downside risk or as a speculative bearish position anticipating a further decline.

Given the stock’s recent three-day decline, the put buyers could be positioning for continued weakness. However, the fact that the stock remains above all major moving averages except the very short-term 5-day suggests that the broader trend remains intact. The Rs 1,820 strike also aligns closely with a technical support zone near the 50-day moving average, which may be a natural level for hedging rather than outright bearish speculation.

Alternatively, the put activity could represent put writing, where sellers collect premium expecting the stock to hold above the strike. However, the turnover and open interest data do not strongly support a dominant put writing narrative here, as the open interest is only slightly higher than the contracts traded, indicating fresh positioning rather than premium collection.

This leads to a nuanced interpretation where the strike distance is the first clue about intent — what does the full data set reveal about the nature of this put activity?

Interpretation Framework: Hedging, Bearish Positioning, or Put Writing?

Put options inherently carry ambiguous signals. The three primary interpretations for heavy put activity are: protective hedging of existing long positions, directional bearish bets, or put writing as a bullish income strategy.

In this case, the stock’s recent decline of 3.33% over three days and the ATM strike suggest some bearish positioning. Yet, the stock’s position above key moving averages and the increased delivery volume complicate this view. The rising delivery volume indicates genuine investor participation in the cash market, which often supports the case for hedging rather than outright bearish speculation.

Moreover, the open interest of 2,000 contracts compared to 1,629 contracts traded implies that much of this activity is fresh, but not overwhelmingly so. This ratio suggests a mix of new hedging and some speculative positioning. The lack of a large open interest build-up also reduces the likelihood of aggressive put writing, which typically involves higher open interest relative to traded contracts.

Therefore, the most plausible interpretation is that the put activity at Rs 1,820 is primarily protective, serving as a hedge against short-term volatility following the recent pullback, rather than a pure bearish conviction. Could this protective stance signal caution among longs rather than outright pessimism?

Open Interest and Contracts Analysis

The open interest of 2,000 contracts at the Rs 1,820 strike is only marginally higher than the 1,629 contracts traded on the day, yielding a ratio of approximately 1.23:1. This suggests that a significant portion of the activity represents fresh positioning rather than adjustments to existing positions.

In contrast to call options markets where open interest can be several times the daily volume, this relatively balanced ratio indicates measured activity. The fresh buying of puts near the money, combined with the stock’s recent decline, points to a cautious stance among investors, possibly seeking downside protection rather than aggressive bearish bets.

Additionally, the turnover of ₹8.95 lakhs for these puts is moderate, reflecting a reasonable premium paid for protection without excessive speculative fervour. This aligns with a scenario where investors are managing risk amid short-term volatility rather than positioning for a sharp fall.

Cash Market Context: Technicals and Delivery Volumes

Sun Pharmaceutical Industries Ltd currently trades at Rs 1,833.40, which is 4.83% below its 52-week high of Rs 1,916.60. The stock’s position above its 20-day, 50-day, 100-day, and 200-day moving averages indicates a sustained uptrend over the medium to long term, despite the recent short-term pullback.

The stock’s fall over the last three days contrasts with the rising delivery volume of 16.04 lakh shares on 25 May, which is 15.37% higher than the five-day average. This suggests that the recent decline is accompanied by genuine investor participation rather than thin-volume price moves, which often trigger protective hedging.

The Rs 1,820 put strike roughly corresponds to a support zone near the 50-day moving average, reinforcing the idea that the put activity is a tactical hedge against a potential pullback to this level rather than a bet on a deeper correction. Does this technical alignment support the protective interpretation over bearish conviction?

Fundamental and Market Positioning Brief

Sun Pharmaceutical Industries Ltd is a large-cap leader in the Pharmaceuticals & Biotechnology sector with a market capitalisation of approximately ₹4,41,790 crores. The stock’s recent performance, including a minor underperformance relative to its sector and Sensex, reflects typical sector volatility rather than company-specific weakness.

The put activity at the Rs 1,820 strike, close to the current price, appears to be a tactical response to short-term price fluctuations rather than a fundamental shift in outlook. The stock’s position near its 52-week high and above key moving averages supports this view.

Conclusion: Protective Hedging Over Bearish Positioning

The heavy put option activity at the Rs 1,820 strike on 26 May 2026, involving 1,629 contracts and an open interest of 2,000, coincides with a stock price of Rs 1,833.40 that has recently declined but remains technically supported. The proximity of the strike to the underlying price, combined with rising delivery volumes and the stock’s position above major moving averages, suggests that the put buying is predominantly protective hedging rather than outright bearish speculation.

While some speculative bearish positioning cannot be ruled out given the recent three-day fall, the data points more strongly to investors managing risk amid short-term volatility. The lack of a significant open interest build-up relative to traded contracts also diminishes the likelihood of put writing as a dominant strategy.

For investors weighing the options data alongside the cash market, the question remains: should the recent put activity be viewed as a prudent hedge or a signal of deeper caution?

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →